Search for: "DR. REDDY'S LABORATORIES LIMITED" Results 21 - 40 of 48
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
6 Aug 2017, 1:14 pm
The money KatThe recent interim Patents Court decision of Napp Pharmaceutical Holdings Limited v (1) Dr Reddy's Laboratories (2) Sandoz Limited (and Ohers) [2017] EWHC 1433 (Pat) provides guidance on the issue. [read post]
3 Dec 2016, 10:02 am
No problem, here is the 124th edition of Never Too Early For Christmas References Never Too Late.Festive Feline Level 100Rocket in the Patents Court: Napp Pharmaceutical v Dr Reddy's and SandozThe case of Napp Pharmaceutical Holdings Limited v (1) Dr Reddy's Laboratories (UK) Limited (2) Sandoz Limited [2016] EWCA Civ 1053 was previously reported on the IPKat here (first instance)… [read post]
23 Dec 2009, 12:40 am
(Patent Docs) US: Science Progress article examines impact of gene patents on research (Patent Docs) US: Gene patenting debate continues: round three – Science Friday public debate on National Public Radio (Patent Docs)   Products Circadin (Melatonin) – UK: IPO refuses SPC for Circadin (SPC blog) Dovonex (Calcipoltriol) – UK: EWCA upholds Leo Pharma’s patent: LEO Pharma A/S and LEO Laboratories Limited v. [read post]
4 Jul 2019, 8:53 am
 Another recent High Court decision considered the issue of added matter in detail (Novartis v Dr Reddy's Laboratories [2019] EWHC 92 (Pat), IPKat post here). [read post]
20 May 2009, 5:18 am
: Dr Reddy’s post grant opposition against Pfizer’s Champix patent (Spicy IP) Tanzania generic pharma sector set for growth (Afro-IP) US: ACLU, PUBPAT and others file lawsuit challenging constitutionality of patents on human genes associated with breast and ovarian cancer: Association for Molecular Pathology et al v USPTO et al (Patent Baristas) (Ars Technica) (Patently-O) (IP Watchdog) (The Prior Art) (Patent Docs) (Patents4Life) US: Obvious-type double… [read post]
18 Aug 2017, 5:56 am
 Eibhlin explains the recent Patents Court decision of Napp Pharmaceutical Holdings Limited v (1) Dr Reddy's Laboratories (2) Sandoz Limited (and Ohers) [2017] EWHC 1433 (Pat) which provided guidance on the issue.In memoriam of June Foray: the greatest screen voice whom you probably never heard of, but likely heardNeil pays homage to June Foray, the voice behind a portfolio of character’s such as Lucifer the cat from… [read post]
24 Aug 2011, 12:33 am by Marie Louise
(BIOtechNOW) Matrix tablets and scope of protection: a reader asks (The SPC Blog) UK: Manual of Patent Practice revised to include guidelines for assessing obviousness of ‘selection inventions’ in light of Dr Reddy (IPKat) US: Strength in numbers? [read post]
29 May 2020, 7:51 am by Brenda Fulmer
” 14 manufacturers have pulled their pills from store shelves: American Health Packaging, Amneal Pharmaceuticals Apotex, Appco Pharma, Aurobindo Pharma USA Denton Pharma (dba Northwind Pharmaceuticals) Reddy’s Laboratories, Glenmark Pharmaceuticals Golden State Medical Supply Lannett, Novitium Pharma, Perrigo Precision Dose Sandoz. [read post]
29 May 2020, 7:51 am by Brenda Fulmer
” 14 manufacturers have pulled their pills from store shelves: American Health Packaging, Amneal Pharmaceuticals Apotex, Appco Pharma, Aurobindo Pharma USA Denton Pharma (dba Northwind Pharmaceuticals) Reddy’s Laboratories, Glenmark Pharmaceuticals Golden State Medical Supply Lannett, Novitium Pharma, Perrigo Precision Dose Sandoz. [read post]
10 Nov 2010, 1:11 am by Kelly
Highlights this week included: US government intervenes in patentability of genes – AMP v USPTO (Patent Baristas) (Holman’s Biotech IP Blog) (Intellectual Property Law Blog) (Inovia) (BlawgIT) (IP Osgoode) Temodar (Temozolomide) – US: CAFC limits prosecution laches defense: Cancer Research Technology v Barr Laboratories (Inventive Step) (IPBiz) (Patently-O) (SmartBrief) Italian antitrust authority opens preliminary investigation into whether Pfizer subsidiary… [read post]
1 Jan 2019, 5:10 pm by Ben Vernia
” Of the $2.8 billion in settlements and judgments recovered by the Department of Justice this past fiscal year, $2.5 billion involved the health care industry, including drug and medical device manufacturers, managed care providers, hospitals, pharmacies, hospice organizations, laboratories, and physicians. [read post]